Thinking Out Loud (Blog)

Immune Engineering Cas9: Yes We Can!

The CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated nuclease-9) system has been a model of great promise in the gene therapy research community since 2012. It was initially discovered as the adaptive immune system of certain...

read more

The DIY Movement . . . in Cancer Vaccines

There is huge hope in personalized cancer vaccines. We are working hard to make our Ancer pipeline available for individual patients. Soon, under the aegis of EpiVax Oncology, we hope to open the door to more patients in a number of collaborative. prospective clinical trials. But for now, let’s proceed with caution, because leaping forward too quickly could be dangerous to patients. This is the promise that I made when graduating from medical school, and I stand by it: First, do no harm.

read more

Turkey Talk

When Tofu isn't Turkey . . .  We're in Lisbon at the European Immunogenicity Platform meeting (EIP -OK, somebody has to do it!). Alex Sette just finished his talk about the new IEDB tool for de-immunization. We're thrilled to hear that he's getting on the "OptiMatrix"...

read more